Key Regulatory miRNAs and their Interplay with Mechanosensing and Mechanotransduction Signaling Pathways in Breast Cancer Progression

Abstract

According to the WHO, breast cancer is the most common cancer in women worldwide. Identification of underlying mechanisms in breast cancer progression is the main concerns of researches. The mechanical forces within the tumor microenvironment, in addition to biochemical stimuli such as different growth factors and cytokines, activate signaling cascades, resulting in various changes in cancer cell physiology. Cancer cell proliferation, invasiveness, migration, and, even, resistance to cancer therapeutic agents are changed due to activation of mechanotransduction signaling. The mechanotransduction signaling is frequently dysregulated in breast cancer, indicating its important role in cancer cell features. So far, a variety of experimental investigations have been conducted to determine the main regulators of the mechanotransduction signaling. Currently, the role of miRNAs has been well-defined in the cancer process through advances in molecular-based approaches. miRNAs are small groups of RNAs (22 nucleotides) that contribute to various biological events in cells. The central role of miRNAs in the regulation of various mediators involved in the mechanotransduction signaling has been well clarified over the last decade. Unbalanced expression of miRNAs is associated with different pathologic conditions. Overexpression and downregulation of certain miRNAs were found to be along with dysregulation of mechanotransduction signaling effectors. This study aimed to critically review the role of miRNAs in the regulation of mediators involved in the mechanosensing pathways and clarify how the cross-talk between miRNAs and their targets affect the cell behavior and physiology of breast cancer cells.

Association of PON1, LEP and LEPR Polymorphisms with Susceptibility to Breast Cancer: A Meta-Analysis

“…Heightened awareness of breast cancer risk in the past decades has led to an increase in the detection methods which can be used to detect the breast cancer in the early stages (Dinegde and Xuying, 2017). In the more affluent countries, mammography screening has been in place for a few decades and has successfully reduced mortality (Motamedi et al, 2012;Najminejad et al, 2020;Esmaeili et al, 2021). However, in developing countries, screening and paid little attention to fight with breast cancer is one of the lowest priorities in health policy (Gallicchio et al, 2007;Liu and Liu, 2011).…”

The role of altered microRNA expression in premalignant and malignant head and neck lesions with epithelial origin

“…It is demonstrated when the expression of specific miRNA is altered in contrast to normal cell expression, they can play an oncogenic role or tumor suppressor function. 73,74 This can be generalized to a wide range of cancers.…”

“…However, unique miRNA has complicated function; one miRNA can target multiple genes and one gene can attach to various miRNAs, but this point is more accentuated when unique miRNA plays a double edge function. It is demonstrated when the expression of specific miRNA is altered in contrast to normal cell expression, they can play an oncogenic role or tumor suppressor function 73,74 . This can be generalized to a wide range of cancers.…”

Phosphatidylinositol 3-kinase signaling inhibitors for treatment of multiple myeloma: From small molecules to microRNAs

“…This biological process profoundly regulates cell proliferation, differentiation, growth, and apoptosis. 79,80 miRNAs are a group of noncoding RNAs with 21 to 25 nt length. These molecules attach to their complementary mRNA in the cytoplasm and lead them to the RISC complex, where their targets will be destroyed.…”